Abnormal uterine bleeding. Hemostatic therapy: hematologist point of view

Abnormal uterine bleeding (AUB) is a common pathology at the confluence of different specialties, mainly occurring in women of reproductive age. There are two main groups of AUB causes: the structural pathology of the female reproductive system and the functional changes, which include the pathology...

Full description

Bibliographic Details
Main Author: Maria A. Vinogradova
Format: Article
Language:Russian
Published: IP Berlin A.V. 2022-04-01
Series:Гинекология
Subjects:
Online Access:https://gynecology.orscience.ru/2079-5831/article/viewFile/104995/pdf
_version_ 1818010127926558720
author Maria A. Vinogradova
author_facet Maria A. Vinogradova
author_sort Maria A. Vinogradova
collection DOAJ
description Abnormal uterine bleeding (AUB) is a common pathology at the confluence of different specialties, mainly occurring in women of reproductive age. There are two main groups of AUB causes: the structural pathology of the female reproductive system and the functional changes, which include the pathology of the hemostatic system, among other things. Regardless of the severity of manifestations, for the efficacy of the treatment, it is important to establish the certain cause of AUB and to choose the precision therapeutic strategy. However, there are universal therapeutic approaches to provide the hemostatic effect, regardless of the etiology of the process. Fibrinolysis inhibitors, in particular, tranexamic acid, are the basis of this approach.
first_indexed 2024-04-14T05:51:26Z
format Article
id doaj.art-66de197372c14cf1b2c34c343c0db43c
institution Directory Open Access Journal
issn 2079-5696
2079-5831
language Russian
last_indexed 2024-04-14T05:51:26Z
publishDate 2022-04-01
publisher IP Berlin A.V.
record_format Article
series Гинекология
spelling doaj.art-66de197372c14cf1b2c34c343c0db43c2022-12-22T02:09:06ZrusIP Berlin A.V.Гинекология2079-56962079-58312022-04-0124215716210.26442/20795696.2022.2.20148379402Abnormal uterine bleeding. Hemostatic therapy: hematologist point of viewMaria A. Vinogradova0https://orcid.org/0000-0001-9827-1922Kulakov National Medical Research Center for Obstetrics, Gynecology and PerinatologyAbnormal uterine bleeding (AUB) is a common pathology at the confluence of different specialties, mainly occurring in women of reproductive age. There are two main groups of AUB causes: the structural pathology of the female reproductive system and the functional changes, which include the pathology of the hemostatic system, among other things. Regardless of the severity of manifestations, for the efficacy of the treatment, it is important to establish the certain cause of AUB and to choose the precision therapeutic strategy. However, there are universal therapeutic approaches to provide the hemostatic effect, regardless of the etiology of the process. Fibrinolysis inhibitors, in particular, tranexamic acid, are the basis of this approach.https://gynecology.orscience.ru/2079-5831/article/viewFile/104995/pdfabnormal uterine bleedingheavy menstrual bleedingwomen of reproductive ageperimenopause bleedingtranexamic acidfibrinolysis inhibitors
spellingShingle Maria A. Vinogradova
Abnormal uterine bleeding. Hemostatic therapy: hematologist point of view
Гинекология
abnormal uterine bleeding
heavy menstrual bleeding
women of reproductive age
perimenopause bleeding
tranexamic acid
fibrinolysis inhibitors
title Abnormal uterine bleeding. Hemostatic therapy: hematologist point of view
title_full Abnormal uterine bleeding. Hemostatic therapy: hematologist point of view
title_fullStr Abnormal uterine bleeding. Hemostatic therapy: hematologist point of view
title_full_unstemmed Abnormal uterine bleeding. Hemostatic therapy: hematologist point of view
title_short Abnormal uterine bleeding. Hemostatic therapy: hematologist point of view
title_sort abnormal uterine bleeding hemostatic therapy hematologist point of view
topic abnormal uterine bleeding
heavy menstrual bleeding
women of reproductive age
perimenopause bleeding
tranexamic acid
fibrinolysis inhibitors
url https://gynecology.orscience.ru/2079-5831/article/viewFile/104995/pdf
work_keys_str_mv AT mariaavinogradova abnormaluterinebleedinghemostatictherapyhematologistpointofview